J.-R. Lin et al. / Tetrahedron Letters 48 (2007) 4987–4989
4989
OH
Br
t-BuOK
HO
DMSO
HO
HO
4
8
Scheme 5. The elimination of 16R-bromopregnane-3S,20S-diol (4).
1
0 equiv of potassium t-butoxide (entry 4). Then, we
3. Tian, W. S.; Guan, H. P.; Pan, X. F. Chin. J. Chem. 2003,
1, 793.
. Yang, Q. X.; Tian, W.-S.; Pan, S. Acta Chim. Sinica 2004,
2, 2171 (in Chinese).
. Marker, R. E.; Turner, D. L.; Wagner, R. B.; Ulshafer,
P. R.; Crooks, H. M., Jr.; Wittle, E. L. J. Am. Chem. Soc.
2
prolonged the reaction time, and found that no change
in the ratio of product 5/6 was observed. This implied
that the reaction time had no effect on the fragmentation
reaction.
4
5
6
1
941, 63, 77.
. Tian, W.-S. CN Patent 96-116304, 1997; Chem. Abstr.
998, 128, 167599.
The influence of the solvent was also observed. Besides
t-butoxy alcohol, dimethyl sulfoxide and dimethyl form-
amide were explored, respectively. In DMF, the oxetane
product 6 was superior, but in DMSO, the predominant
product is pregnan-14,16-dien-3S-ol (8), an elimination-
rearrangement product of 4 (Scheme 5). Moreover, the
effect of a base such as sodium hydride, lithium alumin-
ium hydride and lithium diisopropylamide was exam-
ined. But no satisfactory results were obtained as
expected.
6
1
7. Lin, J. R.; Wang, J.; Chen, L. J.; Wang, Y. C.; Tang, X.
M.; Xu, Q. H.; Zhu, Z.; Tian, W. S. Acta Chim. Sinica
2006, 64, 1265 (in Chinese).
. (a) Pospisek, J.; Vesely, Z.; Trojanek, J. Collect. Czech.
Chem. Commun. 1968, 33, 76; (b) Matsui, M.; Fukushima,
D. K. J. Org. Chem. 1970, 35, 561; (c) Bose, A. K.;
Steinberg, N. G. Synthesis 1970, 11, 595.
8
9
. (a) Cox, P. J.; Tunrner, A. B. Tetrahedron 1984, 40, 3153;
(
1
b) Han, G. D.; Han, G. T.; Zhu, L. Y. Acta Pharm. Sinica
982, 17, 696 (in Chinese); (c) Zhao, M.; Xiang, M. W.;
In conclusion, the reaction of 16R-bromopregnane-
Liao, Q. J. Nanjing Yaoxueyuan Xuebao 1986, 17, 241 (in
Chinese).
3
S,20S-diol with potassium t-butoxide has been investi-
gated in detail. According to the reaction condition
used, fragmentation, intramolecular etherification and
elimination-rearrangement of 16R-bromopregnane-
10. Buckett, W. R.; Hewett, C. L.; Savage, D. S. J. Med.
Chem. 1973, 16, 1116.
1
1. The spectral data of 16R-bromopregnane-3S,20S-diol (4):
25
1
Mp 165–167 °C, ½aꢀ +9.19 (c 0.77, CHCl3); H NMR
3
S,20S-diol with potassium t-butoxide occurred, respec-
D
(
3
400 MHz, CDCl ): d 4.51–4.42 (m, 1H, 16-H), 3.89–3.82
tively. The desired fragmentation reaction provided a
new and concise method for the synthesis of 5a-and-
rost-16-en-3-ol and its analogues from steroidal sapoge-
nins such as tigogenin. The fragmentation product 5 is a
(
m, 1H, 20-H), 3.65–3.57 (m, 1H, 3-H), 0.80 (s, 3H, 18-
Me), 0.65 (s, 3H, 19-Me); IR (KBr): 3415, 2921, 2847,
ꢁ1
1
(
442, 1372, 1041 cm ; MS (EI) m/z (intensity): 381
+
+
+
M ꢁ18), 365 (M ꢁ34), 301 (M ꢁ98). Anal. Calcd for
Br: C, 63.15; H, 8.83. Found: C, 63.36; H, 8.47.
12. The spectral data of androst-16-en-3S-ol (5): Mp 125–
key intermediate for the synthesis of 5a-androst-16-en-
21 35 2
C H O
9
3
-one, as boar sex pheromone. The application of this
1
0
25
D
1
fragmentation reaction for the synthesis of Pavaulon,
127 °C, ½aꢀ +13.29 (c 1.30, CHCl ); H NMR (400 MHz,
3
a steroidal muscle relaxant, is currently in progress in
this laboratory.
CDCl
3
): d 5.84–5.83 (m, 1H, 16-H), 5.69 (d, J = 1.6 Hz,
1
0
1
3
1
1
2
H, 17-H), 3.63–3.56 (m, 1H, 3-H), 0.85 (s, 3H, 18-Me),
1
3
.74 (s, 3H, 19-Me); C NMR (400 MHz, CDCl ): d
3
44.19, 129.51, 71.52, 56.33, 55.42, 45.80, 45.31, 38.44,
7.08, 36.17, 36.00, 34.34, 32.36, 32.24, 31.74, 28.93, 21.45,
7.31, 12.57; IR (KBr): 3346, 3040, 2938, 1611, 1450, 1368,
Acknowledgements
ꢁ
1
+
041, 706 cm ; MS (EI) m/z (intensity): 292 (M +18),
+
57 (M ꢁ17).
We are grateful for financial support of this work by the
National Science Foundation (Nos. 29372077,
1
3. The spectral data of 16S,20S-epoxypregnane-3S-ol (6): Mp
25
1
1
94–196 °C, ½aꢀD +19.56 (c 1.39, CHCl3); H NMR
2
0472052), Shanghai Municipal Education Commission
(
(
400 MHz, CDCl ): d 5.16–5.10 (m, 1H, 20-H), 4.54–4.49
m, 1H, 16-H), 3.63–3.56 (m, 1H, 3-H), 1.47 (d,
3
(
No. 05DZ18).
J = 6.4 Hz, 3H, 21-Me), 1.18 (s, 3H, 18-Me), 0.83 (s,
1
3
3
H, 19-Me); C NMR (400 MHz, CDCl ): d 83.85, 76.50,
3
7
1.28, 57.06, 56.28, 54.58, 45.05, 40.68, 40.09, 38.35, 37.22,
References and notes
35.80, 35.13, 34.83, 32.75, 31.67, 28.84, 23.33, 21.59, 16.13,
2.56; IR (KBr): 3444, 2925, 2848, 1446, 1377, 1054,
1
ꢁ
706 cm ; MS (EI) m/z (intensity): 319 (M +1), 302
+ +
1
+
1
2
. Tian, W. S. Acta Chim. Sinica 1992, 50, 72 (in Chinese).
. Tian, W. S.; Guan, H. P.; Pan, X. F. Chin. Chem. Lett.
994, 5, 1013.
(M ꢁ16), 301 (M ꢁ17). Anal. Calcd for C21
34 2
H O : C,
1
79.19; H, 10.76. Found: C, 78.79; H, 10.36.